Proteome-Wide Alterations of Asymmetric Arginine Dimethylation Associated With Pancreatic Ductal Adenocarcinoma Pathogenesis

Proteome-Wide Alterations of Asymmetric Arginine Dimethylation Associated With Pancreatic Ductal Adenocarcinoma Pathogenesis

Arginine methylation catalyzed by protein arginine methyltransferases (PRMTs) performs essential roles in regulating cancer initiation and progression, but its implication in pancreatic ductal adenocarcinoma (PDAC) requires further elucidation. In this study, asymmetric dimethylarginine (ADMA)-conta...

Full description

Bibliographic Details
Main Authors:	Meijin Wei, Chaochao Tan, Zhouqin Tang, Yingying Lian, Ying Huang, Yi Chen, Congwei Chen, Wen Zhou, Tao Cai, Jiliang Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	protein methylation asymmetric dimethylarginine pancreatic ductal adenocarcinoma PRMT4 label-free quantitative proteomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2020.545934/full

Similar Items

Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations
by: Yufei Yue, et al.
Published: (2015-05-01)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-09-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-02-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Plasma asymmetric dimethylarginine in childhood asthma exacerbation
by: Adel S Bediwy, et al.
Published: (2018-01-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)

Asymmetric and Symmetric Protein Arginine Dimethylation: Concept and Postprandial Effects of High-Fat Protein Meals in Healthy Overweight Men
by: Alexander Bollenbach, et al.
Published: (2019-06-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

MRI Finding of Prostatic Ductal Adenocarcinoma
by: Kazuhiro Kitajima, et al.
Published: (2021-09-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
by: Iwona Bednarz-Misa, et al.
Published: (2020-08-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Simultaneous determination of arginine, citrulline, and asymmetric dimethylarginine in plasma by reverse-phase high-performance liquid chromatography
by: P. V. L. N Srinivasa Rao, et al.
Published: (2017-10-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report
by: Ryo Fujiwara, et al.
Published: (2015-08-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
by: Elena Oliva-Damaso, et al.
Published: (2017-03-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021-08-01)

Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
by: Francesco Perticone, et al.
Published: (2012-10-01)

Plasma levels of catecholamines and asymmetric dimethylarginine levels as predictive values of mortality among hemodialysis patients
by: Dziedzic Marcin, et al.
Published: (2014-06-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke
by: Karin Weissenborn, et al.
Published: (2012-11-01)

Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents
by: Urszula Godula-Stuglik, et al.
Published: (2012-11-01)

Ductal Adenocarcinoma of the Prostate With a Rare Clinical Presentation; Late Gastric Metastasis
by: Hasan Huseyin Tavukcu, et al.
Published: (2016-07-01)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01)

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
by: Gonçalo Mesquita, et al.
Published: (2021-04-01)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01)